These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prospective phase II study of children affected by bilateral intraocular retinoblastoma with macular involvement of both eyes or in the only preserved eye. Macular tumor control, eye preservation rate, and visual outcome. Russo I; Levy-Gabriel C; Dupont A; Lumbroso-Le Rouic L; Cassoux N; Desjardins L; Bertozzi AI; Coze C; Doz F; Savignoni A; Aerts I Pediatr Blood Cancer; 2021 Jan; 68(1):e28721. PubMed ID: 33098751 [TBL] [Abstract][Full Text] [Related]
3. Ocular preservation in patients with bilateral retinoblastoma before chemotherapy in situ era: A report from a Mexican Retinoblastoma Reference Hospital. Del Carmen Bernal-Díaz Z; Murillo-Maldonado MA; Pérez-Villanueva H; Reyes-López A; Ramírez-Ortiz MA Pediatr Blood Cancer; 2020 Oct; 67(10):e28625. PubMed ID: 32743978 [TBL] [Abstract][Full Text] [Related]
9. Factors predictive of long-term visual outcomes of Group D eyes treated with chemoreduction and low-dose IMRT salvage: the Children's Hospital Los Angeles experience. Berry JL; Jubran R; Wong K; Lee TC; Murphree AL; Kim JW Br J Ophthalmol; 2014 Aug; 98(8):1061-5. PubMed ID: 24671926 [TBL] [Abstract][Full Text] [Related]
10. Visual outcomes in children with bilateral retinoblastoma. Hall LS; Ceisler E; Abramson DH J AAPOS; 1999 Jun; 3(3):138-42. PubMed ID: 10428586 [TBL] [Abstract][Full Text] [Related]
11. Visual results in children treated for macular retinoblastoma. Watts P; Westall C; Colpa L; MacKeen L; Abdolell M; Gallie B; Héon E Eye (Lond); 2002 Jan; 16(1):75-80. PubMed ID: 11913894 [TBL] [Abstract][Full Text] [Related]
12. Predictors of long-term visual outcome after chemoreduction for management of intraocular retinoblastoma. Narang S; Mashayekhi A; Rudich D; Shields CL Clin Exp Ophthalmol; 2012; 40(7):736-42. PubMed ID: 22300311 [TBL] [Abstract][Full Text] [Related]
13. [Diagnosis and treatment of retinoblastoma: current strategies for effective tumour control and preservation of vision]. Temming P; Eggert A; Bornfeld N; Sauerwein W; Göricke S; Lohmann DR Klin Monbl Augenheilkd; 2013 Mar; 230(3):232-42. PubMed ID: 23508752 [TBL] [Abstract][Full Text] [Related]
14. Salvage external beam radiotherapy after failed primary chemotherapy for bilateral retinoblastoma: rate of eye and vision preservation. Chan MP; Hungerford JL; Kingston JE; Plowman PN Br J Ophthalmol; 2009 Jul; 93(7):891-4. PubMed ID: 19329423 [TBL] [Abstract][Full Text] [Related]
15. Clinical manifestations and treatment of retinoblastoma in Kobe children's hospital for 16 years. Okimoto S; Nomura K J Pediatr Ophthalmol Strabismus; 2014 Jul; 51(4):222-9. PubMed ID: 24844394 [TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes of Group D eyes in bilateral retinoblastoma patients treated with chemoreduction and low-dose IMRT salvage. Berry JL; Jubran R; Kim JW; Wong K; Bababeygy SR; Almarzouki H; Lee TC; Murphree AL Pediatr Blood Cancer; 2013 Apr; 60(4):688-93. PubMed ID: 22997170 [TBL] [Abstract][Full Text] [Related]
17. Management and outcome of retinoblastoma with vitreous seeds. Manjandavida FP; Honavar SG; Reddy VA; Khanna R Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675 [TBL] [Abstract][Full Text] [Related]
18. [Clinical therapeutic efficiency of chemoreduction and local therapy for children with retinoblastoma]. Qian J; Xue K; Gao YJ; Yuan YF; Shan HD; Bi YW Zhonghua Yan Ke Za Zhi; 2010 Apr; 46(4):312-6. PubMed ID: 20654057 [TBL] [Abstract][Full Text] [Related]